Terumo Recalls CDI 500 Blood Parameter Monitoring System Due to Software Error
Terumo is recalling 3,972 CDI 500 Blood Parameter Monitoring Systems because a software algorithm inaccuracy was discovered during internal testing.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a high-risk medical device used during critical surgical procedures where inaccurate monitoring could lead to patient harm, but no specific injuries or illnesses are reported in the source text.
Plain-English summary
Terumo Cardiovascular Systems Corporation is recalling the CDI Blood Parameter Monitoring System 500 with Arterial blood parameter module. The recall involves 3,972 units that were distributed worldwide, including the United States, Canada, Australia, Japan, and other countries. The devices are intended for use during cardiopulmonary bypass procedures to continuously monitor arterial and venous blood parameters such as pH, PCO2, PO2, K+, oxygen saturation, hematocrit, hemoglobin, and temperature.
The recall was initiated after Terumo discovered through its own testing that the system's software contains inaccuracies associated with a software algorithm. A software update has been developed to address this issue, and a premarket notification (K130425) has been submitted to the FDA. Terumo will implement the update once clearance is received from the agency.
Affected units are identified by catalog number 500A* and specific serial numbers listed in the recall notice. Healthcare facilities and users should contact Terumo Cardiovascular Systems Corporation for instructions on how to obtain the software update.
The recalled product
- Product
- CDI Blood Parameter Monitoring System 500 with Arterial blood parameter module. Intended for use during cardiopulmonary bypass procedures when continuous monitoring of arterial and/or venous pH, PCO2, PO2, K+, oxygen saturation, hematocrit, hemoglobin, and temperature are desi
- Manufacturer
- Terumo Cardiovascular Systems Corporation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Catalog number: 500A* and serial numbers: 1211
- 1559-1563
- 1663-1666
- 1722-1727
- 1754-1758
- 1776
- 1795
- 1951
- 1952
- 2016
- 2112
- 2117
- 2190
- 2246
- 2273
- 2274
- 2322
- 2355
- 2356
- 2389-2391
Distribution
Part of a larger recall action
This product is one of 5 recalled by Terumo Cardiovascular Systems Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Terumo Cardiovascular Systems Corporation
See all →- HighCDI OneView System BPM Probe temperature sensor measurement inaccuracy
FDA (Devices) · 2025-07-02
- HighTerumo CDI OneView Monitor Probe May Fail to Display Oxygen Saturation Data
FDA (Devices) · 2025-04-09
- HighCardiovascular Procedure Kits Recalled for Pressure Relief Valve Defect
FDA (Devices) · 2024-04-10
- HighCAPIOX FX25 Oxygenator Recalled for Potential Leaks from Improper Bonding
FDA (Devices) · 2023-04-12
- HighTerumo Recalls CAPIOX NX19 Oxygenator Due to Improper Bonding
FDA (Devices) · 2023-04-12
Same hazard · software error
See all →- HighQuantum Rehab R-TRAK Powered Wheelchair Controller Recalled Due to Software Issue
FDA (Devices) · 2026-08-12
- HighDASH Rapid PCR Instrument Recalled Due to Software Issue Causing False Co-infection Results
FDA (Devices) · 2026-08-12
- HighQuantum Outback Powered Wheelchair Controller Recalled Due to Unexpected Braking Risk
FDA (Devices) · 2026-08-12
- HighREMISOL Advance Software Version 2.5 Recalled for Incorrect Test Result Reporting
FDA (Devices) · 2026-08-12
- HighQuantum Rehab Q6 Edge 3 Powered Wheelchair Controller Recalled for Unexpected Braking
FDA (Devices) · 2026-08-12